A therapeutic vaccine for Parkinson’s disease and multiple system atrophy (MSA) is the primary objective of a group of leading research teams across Europe, Austrian pharmaceutical company Affiris announced April 28.

The duration and severity of type 2 diabetes may be associated with brain degeneration, according to a study published online April 29 by Radiology. Contrary to common belief, the research also found that diabetes may not be directly associated with small vessel ischemic disease (SVID).

The University Hospital 12 de Octubre in Madrid announced April 15 that the institution was using investigational technology to manage Parkinson’s tremor. The robotic glove attaches to patients via electrodes and reduces the hallmark symptom of the neurodegenerative disease.

A 3D atlas of genetic activity in the human brain prior to birth is now available for research and the public, the National Institutes of Health announced earlier this month. The map was designed to further brain disorders including schizophrenia and autism.

Eli Lilly and Company announced first quarter 2014 earnings yesterday, including $0.68 per share and an overall 16 percent decline compared to the previous quarter due to U.S. patent expirations on popular drugs.

Mark your calendars for Wednesday, April 30. That’s the day that representatives from the American College of Radiology, the Lung Cancer Alliance and a number of other organizations will go before the 2014 Medicare Evidence Development and Coverage Advisory Committee seeking to make the case for national Medicare coverage of low dose CT screening for patients at high risk for lung cancer.

The buzz is all about digital breast tomosynthesis (DBT). Experts weigh in on its prowess, performance and power in cutting recalls. Is it ready for primetime?

Contrast material-enhanced ultrasonography (US) is a highly sensitive and specific method for characterization of indeterminate renal masses, according to a study published in the April issue of Radiology.